Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cationic antimicrobial peptides: towards clinical applications.

R E Hancock1

  • 1University of British Columbia, 6174 University Boulevard, Vancouver, BC V6T 1Z3, Canada.

Expert Opinion on Investigational Drugs
|November 4, 2000
PubMed
Summary

Cationic antimicrobial peptides, vital for innate immunity, show broad therapeutic potential. Clinical trials are underway for topical and parenteral applications against infections and inflammation.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Isolation and Characterization of Porins from H. pylori.

Methods in molecular medicine·2011
Same author

Characterization and Chemical Modification of Small Anion Specific Channels formed in Lipid Bilayer Membranes by Outer Membrane Protein P or Pseudomonas aeruginosa.

Biophysical journal·2009
Same author

The therapeutic potential of cationic peptides.

Expert opinion on investigational drugs·2005
Same author

Characterization of, and immune responses of mice to, the purified OmpA-equivalent outer membrane protein of Pasteurella multocida serotype A:3 (Omp28).

Veterinary microbiology·2002
Same author

Cationic peptides: effectors in innate immunity and novel antimicrobials.

The Lancet. Infectious diseases·2002
Same author

In vitro aerosol delivery and regional airway surface liquid concentration of a liposomal cationic peptide.

Journal of pharmaceutical sciences·2001

Area of Science:

  • Biochemistry
  • Immunology
  • Microbiology

Background:

  • Cationic antimicrobial peptides (CAPs) are crucial elements of innate immunity across species.
  • Natural CAP variants exhibit diverse antimicrobial, antifungal, antiviral, and anti-endotoxic activities.
  • These peptides are being explored for therapeutic applications due to their broad-spectrum efficacy.

Purpose of the Study:

  • To investigate the therapeutic potential of cationic antimicrobial peptides.
  • To evaluate the efficacy of CAPs in clinical settings for various conditions.

Main Methods:

  • Review of existing literature on CAPs and their activities.
  • Analysis of data from early and Phase III clinical trials.
  • Assessment of CAPs for topical and parenteral administration.

Main Results:

  • Two CAPs demonstrated efficacy in early clinical trials for oral mucositis and catheter sterilization.
  • These CAPs are progressing through Phase III clinical trials for topical use.
  • The cationic protein rBPI 21 completed Phase III trials for parenteral treatment of meningococcaemia.

Conclusions:

  • Cationic antimicrobial peptides represent a promising class of therapeutic agents.
  • Ongoing clinical investigations support their potential in treating infections and inflammatory conditions.
  • CAPs are being developed for both topical and parenteral applications, highlighting their versatility.

Related Experiment Videos